Draft Guidance Addresses Risk to Offspring of Father’s Drug Use

Clinical Trials Advisor
A A
The FDA wants drugmakers to assess the risks of active pharmaceutical ingredients taken by men on the development of embryos and fetuses of their female partners.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00